ACME Laboratories Ltd 2019 AR2
The report for the fiscal year 2018-2019 highlights ACME's achievement of UK MHRA certification for its solid dosages unit, facilitating entry into European markets. The company successfully commenced commercial operations for its Steroid & Hormone and Penicillin projects, which are expected to drive future growth. Sustainability efforts are framed within a Triple Bottom Line approach, focusing on social welfare, environmental conservation, and economic performance. Notably, the report includes a dedicated section on the conservation of the Palmyra palm to mitigate climate change and natural disasters. ACME also reported a 10.09% increase in revenue and maintained a consistent dividend policy.
Company: ACME Laboratories Ltd
Sector: Manufacturing
Country: Bangladesh
Year: 2019
Type: AR2
Pages: 159
Back to company
ACME Laboratories Ltd
Annual Report
The report for the fiscal year 2018-2019 highlights ACME's achievement of UK MHRA certification for its solid dosages unit, facilitating entry into European markets. The company successfully commenced commercial operations for its Steroid & Hormone and Penicillin projects, which are expected to drive future growth. Sustainability efforts are framed within a Triple Bottom Line approach, focusing on social welfare, environmental conservation, and economic performance. Notably, the report includes a dedicated section on the conservation of the Palmyra palm to mitigate climate change and natural disasters. ACME also reported a 10.09% increase in revenue and maintained a consistent dividend policy.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2019
Reporting Period
Jul 1, 2018 - Jun 30, 2019
Fiscal Year
2019
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Employees